Severe Hyperhomocysteinemia in a Patient with Parkinson Disease
Open Access
- 26 February 2022
- journal article
- editorial
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 68 (3) , 396-401
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Tryptophan catabolites as metabolic markers of vitamin B-6 status evaluated in cohorts of healthy adults and cardiovascular patientsThe American Journal of Clinical Nutrition, 2020
- Changes in kynurenine pathway metabolism in Parkinson patients with L‐DOPA‐induced dyskinesiaJournal of Neurochemistry, 2017
- Vitamin B12 deficiencyNature Reviews Disease Primers, 2017
- Lower hemoglobin levels in patients with parkinson's disease are associated with disease severity and iron metabolismBrain Research, 2017
- Molecular and biochemical investigations of patients with intermediate or severe hyperhomocysteinemiaMolecular Genetics and Metabolism, 2016
- Revisiting the Evidence for Neuropathy Caused by Pyridoxine Deficiency and ExcessJournal of Clinical Neuromuscular Disease, 2014
- The kynurenine pathway in neurodegenerative diseases: Mechanistic and therapeutic considerationsJournal of the Neurological Sciences, 2012
- Levodopa-induced hyperhomocysteinaemia in Parkinson's diseaseActa Neurologica Scandinavica, 2003
- Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficienciesThe American Journal of Medicine, 1994
- An evaluation of trace metals, vitamins, and taste function in anorexia nervosaThe American Journal of Clinical Nutrition, 1980